Back to Journals » ImmunoTargets and Therapy » Volume 10
ImmunoTargets and Therapy
ISSN: 2253-1556
- View all (172)
- Volume 13, 2024 (17)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 10, 2021
Pathophysiology of Non-IgE-Mediated Food Allergy
Zhang S, Sicherer S, Berin MC, Agyemang A
ImmunoTargets and Therapy 2021, 10:431-446
Published Date: 29 December 2021
Understanding and Managing Severe Asthma in the Context of COVID-19
Kong-Cardoso B, Ribeiro A, Aguiar R, Pité H, Morais-Almeida M
ImmunoTargets and Therapy 2021, 10:419-430
Published Date: 11 December 2021
The Role of IL-17 Cytokines in Psoriasis
Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T
ImmunoTargets and Therapy 2021, 10:409-418
Published Date: 24 November 2021
Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies
Karmakar S, Pal P, Lal G
ImmunoTargets and Therapy 2021, 10:387-407
Published Date: 1 November 2021
The Role of Complement in Synaptic Pruning and Neurodegeneration
Gomez-Arboledas A, Acharya MM, Tenner AJ
ImmunoTargets and Therapy 2021, 10:373-386
Published Date: 24 September 2021
Immunotherapy of Multiple Myeloma: Promise and Challenges
Abramson HN
ImmunoTargets and Therapy 2021, 10:343-371
Published Date: 9 September 2021
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
Arneson LC, Carroll KJ, Ruderman EM
ImmunoTargets and Therapy 2021, 10:333-342
Published Date: 28 August 2021
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
Levy M, Mealy MA
ImmunoTargets and Therapy 2021, 10:325-331
Published Date: 20 August 2021
Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
Bughda R, Dimou P, D'Souza RR, Klampatsa A
ImmunoTargets and Therapy 2021, 10:313-323
Published Date: 5 August 2021
Alopecia Areata: An Autoimmune Disease of Multiple Players
Suchonwanit P, Kositkuljorn C, Pomsoong C
ImmunoTargets and Therapy 2021, 10:299-312
Published Date: 29 July 2021
Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology
Unterberger S, Davies KA, Rambhatla SB, Sacre S
ImmunoTargets and Therapy 2021, 10:285-298
Published Date: 28 July 2021
Complement Inhibition and COVID-19: The Story so Far
Fodil S, Annane D
ImmunoTargets and Therapy 2021, 10:273-284
Published Date: 26 July 2021
Cannabis and Autoimmunity: Possible Mechanisms of Action
Giorgi V, Marotto D, Batticciotto A, Atzeni F, Bongiovanni S, Sarzi-Puttini P
ImmunoTargets and Therapy 2021, 10:261-271
Published Date: 21 July 2021
The Cancer-Immunity Cycle in Multiple Myeloma
Casey M, Nakamura K
ImmunoTargets and Therapy 2021, 10:247-260
Published Date: 16 July 2021
Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era
Kasarello K, Mirowska-Guzel D
ImmunoTargets and Therapy 2021, 10:237-246
Published Date: 7 July 2021
Targeting CD22 for the Treatment of B-Cell Malignancies
Shah NN, Sokol L
ImmunoTargets and Therapy 2021, 10:225-236
Published Date: 6 July 2021
Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches
Takaiwa F
ImmunoTargets and Therapy 2021, 10:213-224
Published Date: 2 July 2021
CD38-Directed Therapies for Management of Multiple Myeloma
Hashmi H, Husnain M, Khan A, Usmani SZ
ImmunoTargets and Therapy 2021, 10:201-211
Published Date: 29 June 2021
VISTA: A Promising Target for Cancer Immunotherapy?
Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M
ImmunoTargets and Therapy 2021, 10:185-200
Published Date: 22 June 2021
Memory Generation and Re-Activation in Food Allergy
Koenig JFE, Bruton K, Phelps A, Grydziuszko E, Jiménez-Saiz R, Jordana M
ImmunoTargets and Therapy 2021, 10:171-184
Published Date: 9 June 2021
NHS-IL12, a Tumor-Targeting Immunocytokine
Greiner JW, Morillon II YM, Schlom J
ImmunoTargets and Therapy 2021, 10:155-169
Published Date: 27 May 2021
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
Atzeni F, Carriero A, Boccassini L, D'Angelo S
ImmunoTargets and Therapy 2021, 10:141-153
Published Date: 3 May 2021
Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
Xu N, Tse B, Yang L, Tang TCY, Haber M, Micklethwaite K, Dolnikov A
ImmunoTargets and Therapy 2021, 10:123-140
Published Date: 28 April 2021
TNFR2: Role in Cancer Immunology and Immunotherapy
Yang Y, Islam MS, Hu Y, Chen X
ImmunoTargets and Therapy 2021, 10:103-122
Published Date: 21 April 2021
Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?
Held F, Klein AK, Berthele A
ImmunoTargets and Therapy 2021, 10:87-101
Published Date: 19 March 2021
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F
ImmunoTargets and Therapy 2021, 10:63-85
Published Date: 9 March 2021
Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent
Barros PO, Berthoud TK, Aloufi N, Angel JB
ImmunoTargets and Therapy 2021, 10:47-62
Published Date: 8 March 2021
Anti-IgE for the Treatment of Chronic Urticaria
Wedi B, Traidl S
ImmunoTargets and Therapy 2021, 10:27-45
Published Date: 17 February 2021
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
Passiglia F, Reale ML, Cetoretta V, Novello S
ImmunoTargets and Therapy 2021, 10:9-26
Published Date: 5 February 2021
Current Insights into Immunotherapy Approaches for Food Allergy
Macdougall JD, Burks AW, Kim EH
ImmunoTargets and Therapy 2021, 10:1-8
Published Date: 27 January 2021